ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

14 links0 made here, not in the record27 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04164199Study of Tislelizumab,Pamiparib, and OtherInvestigational Agents inParticipants With AdvancedMalignanciesBeOne MedicinesPhase 3 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSAdvanced MalignanciesNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSTislelizumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPamiparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTemozolomideIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundSitravatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOciperlimabIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundBAT1706Intervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundHMPL-013Entry “Fruquintinib”, read by our nam…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT010898Entry “BGB-15025”, read by our name r…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedZanidatamabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT017610Entry “BGB-A445”, read by our name ru…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT014985Entry “Surzebiclimab”, read by our na…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundLenvatinibIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerAlcestobartEntry “LBL-007”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Tislelizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Tislelizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TislelizumabClaude Opus 5.5TestedCurrent
Nov 2PamiparibClaude Opus 5.5TestedCurrent
Nov 2TemozolomideClaude Opus 5.5BackgroundCurrent
Nov 2SitravatinibClaude Opus 5.5TestedCurrent
Nov 2OciperlimabClaude Opus 5.5BackgroundCurrent
Nov 2BAT1706Claude Opus 5.5BackgroundCurrent
Nov 2HMPL-013Claude Opus 5.5BackgroundCurrent
Nov 2INT010898Claude Opus 5.5TestedCurrent
Nov 2ZanidatamabClaude Opus 5.5TestedCurrent
Nov 2INT017610Claude Opus 5.5BackgroundCurrent
Nov 2INT014985Claude Opus 5.5BackgroundCurrent
Nov 2LenvatinibClaude Opus 5.5Background · partnerCurrent
Nov 2AlcestobartClaude Opus 5.5BackgroundCurrent
Nov 14Advanced MalignanciesRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18TislelizumabRule based · role ruleTestedAgrees
Nov 18PamiparibRule based · role ruleTestedAgrees
Nov 18TemozolomideRule based · role ruleBackgroundAgrees
Nov 18SitravatinibRule based · role ruleTestedAgrees
Nov 18OciperlimabRule based · role ruleBackgroundAgrees
Nov 18BAT1706Rule based · role ruleBackgroundAgrees
Nov 18HMPL-013Rule based · role ruleBackgroundAgrees
Nov 18INT010898Rule based · role ruleTestedAgrees
Nov 18ZanidatamabRule based · role ruleTestedAgrees
Nov 18INT017610Rule based · role ruleBackgroundAgrees
Nov 18INT014985Rule based · role ruleBackgroundAgrees
Nov 18LenvatinibRule based · role ruleBackgroundAgrees
Nov 18AlcestobartRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.